Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone and Eye Tracking in Gambling Disorder
NCT04738773Phase 2Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of naltrexone in gambling disorder (GD), sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
naltrexone
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on NCT04738773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04738773.